We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




RTS Life Sciences to Produce Robotic Blood System

By HospiMedica staff writers
Posted on 17 Apr 2006
RTS Life Sciences (Manchester, UK) has won a contract to design and install an automated robotic system incorporating machine vision for the new UK Biobank (Cheadle, UK).

The contract follows the development of a prototype vision system by the company. More...
The full fractionation system will be commissioned in the second quarter of 2006, by which time it will be fully integrated with Biobank's software and database.

The UK Biobank aims to build a major resource to support research that will improve the prevention, diagnosis, and treatment of illness and promote health throughout society. The project will follow the health of 500,000 volunteers for up to 30 years, collecting information on environment and lifestyle factors, and linking these to medical records and biologic samples.

Paul Downey, director of laboratory operations at the UK Biobank, explained that the research would require approximately 3,500 samples of blood to be processed each day. In addition to the large number of technicians this output would require, there are the serious health aspects of exposing people to such large amounts of unscreened blood.

When blood is centrifuged at low speeds, it separates into three fractions: plasma, the buffy coat containing the white blood cells, and erythrocytes. The RTS system centrifuges the blood into individual containers, identifies each sample, identifies the fractions, and aliquots the chosen fraction into arrays of 96 x1 ml tubes. A digital camera takes two images and software analyzes the images to determine the exact boundaries between the layers. The layers are then converted into liquid handling protocols and mapped to destination tubes before the robot aliquots the layers into tubes prior to storage or preparation for assays.

The UK Biobank will collect and store all fractions of blood as each fraction can reveal something different about an individual's health, and because more detailed assays will be developed in the future.



Related Links:
RTS Life Sciences
UK Biobank

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.